Research

White Paper: Using AI to Discover Targets and Mechanism of Action from High-Content Imaging Screen

BioSymetrics is applying artificial intelligence (AI) and machine learning capabilities to the discovery and development of new drugs using a proprietary Contingent AI™ platform.

‍